- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Alison Conlin, MD | Authors
Metastatic Triple-Negative Breast Cancer: Unmet Needs and Future Directions in Care
December 05, 2022
Expert oncologists highlight remaining unmet needs in the setting of metastatic triple-negative breast cancer and look toward future evolutions in care.
Interpreting Data From ASCENT: Practical Use of Sacituzumab Govitecan in mTNBC
December 05, 2022
Centering discussion on sacituzumab govitecan use in metastatic triple-negative breast cancer, expert oncologists reflect on results from the phase 3 ASCENT study.
Sacituzumab Govitecan in mTNBC: Results From the ASCENT Study
November 30, 2022
Centering discussion on sacituzumab govitecan use in metastatic triple-negative breast cancer, expert oncologists reflect on results from the phase 3 ASCENT study.
Metastatic Triple-Negative Breast Cancer: An Evolving Treatment Landscape
November 30, 2022
Key opinion leaders Aditya Bardia, MD, MPH, and Alison Conlin, MD, provide a broad view of the current metastatic triple-negative breast cancer treatment landscape.